Ageing is associated with altered sympathetic responses to stress, which are explained in part by reduced noradrenergic function. The impact of supplementation with oral l-tyrosine, the amino acid precursor for catecholamine synthesis, on the effector responses to cold and exercise stress has yet to be examined. r What is the main finding and its importance?
Introduction
An increase in sympathetic nerve activity is an important homeostatic response to exercise or thermal stress. Sufficient L-tyrosine, the amino acid substrate for the rate-limiting enzyme of catecholamine biosynthesis (i.e. tyrosine hydroxylase, TH), is required to sustain increased catecholamine biosynthesis and release (Acworth et al. 1988; Kumer & Vrana, 1996) . Although L-tyrosine is generally not thought to limit adrenergic function (Benedict et al. 1983) , increased catecholamine synthesis during stressful conditions may deplete axonal tyrosine pools in the immediate vicinity of TH within sympathetic nerve terminals and blunt end-organ responses (Lovenberg et al. 1975; Weiner et al. 1978; Fernstrom et al. 1986 ). This may be more functionally evident in older adults, in whom bioavailable tyrosine might be further reduced by oxidative and nitrosative stress (Reiter et al. 2000; Blanchard-Fillion et al. 2001; Kochman et al. 2002) .
Ageing is associated with a reduced sympathetic cutaneous vasoconstriction (VC) response to whole-body cold stress (Kenney & Armstrong, 1996; Thompson & Kenney, 2004; Lang et al. 2009 ). In contrast to young adults, older adults rely on a blunted noradrenergic response to elicit reflex cutaneous VC (Thompson et al. 2005; Lang et al. 2010) . Consequently, reduced VC in older adults results in excess heat loss and increases the susceptibility to hypothermia even in mildly cool ambient conditions (Kenney & Armstrong, 1996; DeGroot & Kenney, 2007) . Interestingly, localized perfusion of a small area of skin with L-tyrosine normalized the VC response in older adults to match that of young adults (Lang et al. 2010 ). However, whether or not this occurs with oral supplementation of tyrosine or if tyrosine affects other end-organ responses to stressors such as static hand-grip exercise has yet to be examined.
As an extension of previous work examining localized administration of L-tyrosine (Lang et al. 2010) , the primary purpose of this study was to determine whether orally supplemented tyrosine altered cutaneous VC during whole-body cooling in older adults. Studies in which oral supplementation of L-tyrosine has been implemented during cold stress have demonstrated that tyrosine enhances cognitive and psychomotor performance in young adults (Banderet & Lieberman, 1989; Mahoney et al. 2007; O'Brien et al. 2007) ; however, the thermoregulatory or microvascular benefit of L-tyrosine ingestion in older adults is unclear. A secondary goal of this study was to examine whether or not additional stress posed by combined cooling and static hand-grip exercise with postexercise limb occlusion would alter the pressor response in older adults. With combined stressors, there would presumably be a greater demand for L-tyrosine. Although a recent study has demonstrated that the pressor response to static hand-grip exercise during whole-body cooling in older adults is preserved (Greaney et al. 2014) , it is unclear how this might be affected by tyrosine supplementation. Collectively, we hypothesize that oral L-tyrosine ingestion in older adults will augment their reflex VC response in skin and increase the pressor response to static hand-grip exercise and postexercise ischaemia.
Methods

Subjects
Experimental protocols were approved by the institutional review board of Des Moines University (approval no. 07-13-04) and conformed to the standards set by the Declaration of Helsinki. Written and verbal consent were obtained voluntarily from 11 young (24 ± 1 years of age, seven women and four men) and 11 older subjects (68 ± 4 years of age, six women and five men). All subjects were healthy, non-obese, normotensive, normal cholesterolaemic, non-smokers and not taking any medications or vitamin supplements that might alter cardiovascular or thermoregulatory function (Table 1) . Young women were studied in the early follicular phase of the menstrual cycle or in the low-hormone phase of oral contraceptive use. Older women were not using hormone replacement therapy. On the day of an experiment, subjects arrived at the laboratory after abstention from alcohol and caffeine (for >12 h) as well as strenuous physical activity and vitamin supplementation (for >24 h). Participants were instructed to eat a light breakfast devoid of tyrosine-rich food >3 h before the experiment and then fast thereafter.
All participants recorded what they ingested for meals the evening before and the morning of the experiment and replicated these meals for the second experiment. Tyrosine augments reflex vasoconstriction in older adults
Instrumentation
Upon arrival at the laboratory (room temperature = 23°C) in the morning (08.00-13.00 h), participants were given either 150 mg kg −1 L-tyrosine or placebo in a double-blind, randomized crossover study design. At least 72 h separated experimental days to ensure an adequate washout period. Tyrosine, or placebo, was compounded into small gel capsules (Buderer Drug Co., Sandusky, OH, USA). The 150 mg kg −1 oral dose of tyrosine was based upon previous studies Tumilty et al. 2011 Tumilty et al. , 2014 Watson et al. 2012) . This dose was piloted in six participants to verify when peak plasma tyrosine concentration occurred and that tyrosine would remain elevated throughout the experimental time period. Pilot experiments consisted of I.V. cannula placement in the antecubital vein for blood sampling before (pre-ingestion plasma [tyrosine] = 69 ± 13 nmol ml −1 ) and throughout a 4 h period after ingestion of 150 mg kg −1 L-tyrosine (post-ingestion plasma [tyrosine] (in nmol ml −1 ): 30 min = 122 ± 17, 60 min = 214 ± 47, 90 min = 254 ± 117, 120 min = 253 ± 115 and 240 min = 243 ± 80).
After oral ingestion of L-tyrosine or placebo, participants donned a water-perfused suit that covered the entire body, with the exception of the face, hands, feet and forearms. Then, subjects were in a semirecumbent position for the remainder of the experiment, with arms at heart level. Copper-constantan thermocouples were placed on the surface of the skin at six sites: calf, thigh, abdomen, chest, back and upper arm. The unweighted mean of these sites provided an index of mean skin temperature (T sk ). Oral temperature (T OR ) was measured using a sublingual thermistor at baseline and toward the end of the cooling bout to provide an index of the change in body core temperature. Oral temperature increased slightly with cooling in young ( T OR = 0.05°C) and older adults ( T OR = 0.01°C). Arterial blood pressure was measured via automated brachial cuff (Tango M2; Suntech Medical, Morrisville, NC, USA). Mean arterial pressure (MAP) was calculated as the diastolic blood pressure plus one-third of the pulse pressure. Heart rate (HR) was continuously recorded using a lead II ECG (CT-1000 cardiotachometer; CWE Inc., Ardmore, PA, USA). Respiratory movements were monitored using a strain gauge piezoelectric transducer placed around the abdomen to ensure that the participant did not inadvertently perform a Valsalva manoeuvre or breath-hold during hand-grip exercise (Pnumotrace II; UFI, Morro Bay, CA, USA).
To obtain an index of skin blood flow, red blood cell flux [laser Doppler flux (LDF)] was continuously measured with multifibre integrated laser Doppler flowmetry probes (moorVMS-LDF; Moor Instruments, Axminster, UK).
Probes were placed in the centre of local heaters (moorVMS-HEAT; Moor Instruments) and positioned on the ventral forearm of the non-dominant side. Local heaters were set at 33°C throughout the experiment to ensure that any vasomotor changes were reflex in origin. Cutaneous vascular conductance (CVC) was calculated as the ratio of LDF to MAP and expressed as a percentage change from baseline (% CVC baseline ).
In addition to LDF, which measures over a limited area (1 mm 2 ), venous occlusion plethysmography was used to collect entire forearm blood flow (FBF). The FBF measures were collected on the dominant arm at baseline and every 0.5°C drop in T sk (EC6 Plethysmograph; Hokanson, Bellevue, WA, USA). For each measure, blood flow to the hand was arrested with instantaneous wrist cuff inflation to 200 mmHg. Concomitantly, an arm cuff was inflated to 50 mmHg to prevent venous outflow. Over a 10 s period, venous inflow was measured using a mercury-in-Silastic strain gauge placed on the proximal forearm. Measurements were repeated three to five times, with ß10 s between each measurement (Whitney, 1953) . Forearm vascular conductance (FVC) was calculated as FBF divided by MAP.
Protocol
After instrumentation and ß80 min post-ingestion of L-tyrosine or placebo, subjects used their dominant hand to attempt three to five maximal isometric hand-grip efforts each separated by ß1 min. The highest force produced was taken as their maximal voluntary contraction (MVC). After baseline data had been collected for ß10 min, the first isometric hand-grip bout commenced. Participants performed 2 min of isometric hand-grip exercise at 35% MVC. The force evoked was displayed on an overhead screen to provide visual feedback. During the last 5 s of exercise, an arm cuff was inflated to suprasystolic pressure for 3 min. After the 3 min postexercise ischaemia (PEI) period, the arm cuff was deflated.
Following exercise and selective metaboreflex activation, baseline was re-established over a 15 min resting period. Then, whole-body cooling commenced. During the first 30 min of cooling, T sk was gradually reduced to 30.5°C. Blood pressure and FBF measurements were collected at each 0.5°C decline in mean skin temperature. Upon reaching peak cooling (T sk = 30.5°C), skin temperature was maintained for an additional 15 min while FBF measurements were collected and participants performed a second bout of isometric hand-grip exercise, repeating the same procedure as described at baseline, after which participants were rewarmed in the suit to their personal comfort level and deinstrumented. MAP (mmHg) Young 89 ± 8 8 8 ± 7 9 4 ± 7 9 2 ± 5 Older 93 ± 7 9 3 ± 9 100 ± 10 102 ± 11 † ‡ HR (beats min −1 ) Young 62 ± 9 6 4 ± 9 6 3 ± 10 62 ± 10 Older 64 ± 8 6 5 ± 9 6 2 ± 8 6 3 ± 9 CVC (flux mmHg −1 ) Young 0.22 ± 0.09 0.33 ± 0.20 0.14 ± 0.06
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Values are means ± SD. Mean arterial pressure (MAP), heart rate (HR), absolute cutaneous vascular conductance (CVC) values and forearm vascular conductance (FVC) values are given for young (n = 11) and older (n = 11) subjects at baseline and maximal cooling [mean skin temperature (T sk ) = 30.5°C]. * P < 0.05 versus placebo; † P < 0.05 versus young; ‡ P < 0.05 versus baseline conditions.
Data acquisition and analysis
Data were collected at 1000 Hz and stored for offline analysis (LabChart v8 and PowerLab 16/35; ADInstruments, Bella Vista, NSW, Australia). The LDF data were processed into 1 s averages every fourth second throughout the protocol. Both CVC and FVC were calculated for every 0.5°C drop in T sk during cooling. Blood pressure and heart rate responses were determined for the last 15 s of each minute of hand-grip exercise, PEI and recovery. For each dependent variable, a three-way mixed-model ANOVA followed by Bonferroni post hoc analysis was conducted (SPSS version 22; SPSS, Chicago, IL, USA) to detect drug treatment effects at different time/temperature points in the protocol between age groups. Subject characteristics between age groups were analysed using Student's unpaired t tests. Statistical significance was set at α = 0.05. An a priori sample size analysis was performed, which indicated that 11 participants were needed to detect significant differences at P < 0.05 and 80% power. Data are represented as means ± SD.
Results
Subject characteristics are presented in Table 1 . Groups were well matched with regard to anthropometric parameters. Although total and low-density lipoprotein cholesterol were higher in older adults (P < 0.05), there was no difference with respect to high-density lipoprotein cholesterol or cholesterol ratio. Older adults also exhibited higher MAP (P = 0.043) and fasting blood glucose (P = 0.014) compared with young adults.
Baseline values for MAP, HR, absolute CVC (calculated as laser Doppler flux per millimetre of mercury) and FVC are presented in Table 2 . In young subjects, CVC values at baseline were generally higher, although not significant, during the L-tyrosine trial (P = 0.057). Additionally, baseline FVC values were higher in young subjects during both trials (P < 0.05). During whole-body cooling, MAP was increased over baseline in older participants during the L-tyrosine trial (P = 0.011), and this value was higher than what was observed in younger adults (P = 0.012). Both CVC and FVC were reduced during cooling in both young and older adults and during both the placebo and tyrosine trials (P < 0.05). The reduction in FVC with cooling was greater in young compared with older adults (P < 0.05). During cooling in older adults, there was also a tendency for lower CVC values (P = 0.120) and FVC values (P = 0.001) with tyrosine supplementation.
The FVC response as a function of decreasing T sk during whole-body cooling with placebo and oral L-tyrosine treatment is illustrated in Fig. 1 . Compared with young subjects, older adults within each trial exhibited lower FVC values toward the onset of cooling and higher FVC values toward the end of cooling (placebo: 33.5 ࣘ T sk ࣘ 32.0°C; L-tyrosine: 33.0 ࣘ T sk ࣘ 31.0°C; P < 0.05). In young adults, the FVC response was unaffected by tyrosine supplementation (Fig. 1A) . However, compared with placebo, older adults exhibited a greater reduction in FVC after ingesting tyrosine (T sk ࣘ 32.0°C; P < 0.05; Fig. 1B) .
The reflex cutaneous VC response was represented as a percentage change in CVC from baseline (% CVC baseline ) for every 0.5°C decrease in T sk during whole-body cooling (Fig. 2) . Compared with young subjects, the VC response to cooling was blunted in older adults (placebo: T sk ࣘ 33.5°C; L-tyrosine: T sk ࣘ 31.5°C; P < 0.05). In young adults, the cutaneous VC response was unaffected by L-tyrosine supplementation ( Fig. 2A) . However, in older adults, L-tyrosine ingestion resulted in a greater reflex VC response compared with placebo (T sk ࣘ 33.0°C; P < 0.05; Fig. 2B ).
Individual participant VC responses to peak cooling (T sk = 30.5°C) across drug treatment are summarized in young (Fig. 3A) and older adults (Fig. 3B) . Group mean and SD are also illustrated. Older adults exhibited a blunted VC response (16 ± 1% CVC baseline ) compared with young adults (39 ± 2% CVC baseline ; P < 0.05). After oral tyrosine supplementation, the VC response to cooling was augmented in older (32 ± 2% CVC baseline ) but not young adults (40 ± 1% CVC baseline ; P < 0.05).
Cardiovascular responses to isometric hand-grip exercise and selective metaboreflex activation in thermoneutral and cooling conditions (T sk = 30.5°C) are shown in Table 3 . The change in blood pressure from baseline during hand-grip exercise or PEI was not different across drug treatment, age group or with cooling. Likewise, the change in HR from baseline was not different. However, compared with young subjects, the increase in HR was lower in older adults during hand-grip exercise (P < 0.05).
Discussion
The primary new finding from this study was that oral L-tyrosine supplementation augmented the reflex cutaneous VC response to whole-body cooling in older but not young adults. These data indicate that L-tyrosine limits cutaneous adrenergic function and suggest that oral L-tyrosine supplementation might improve thermoregulatory function in older adults. Neutral Young 28 ± 12 30 ± 13 1 ± 6 −2 ± 6 Older 12 ± 8 † 11 ± 7 † 0 ± 3 −2 ± 5 Cooling Young 20 ± 17 19 ± 12 * −4 ± 9 −3 ± 6 Older 16 ± 10 14 ± 6 1 ± 5 −2 ± 7
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Group mean change in mean arterial pressure ( MAP) and heart rate ( HR) from baseline during isometric hand-grip exercise and postexercise ischaemia in thermoneutral conditions and during peak cooling (T sk = 30.5°C). * P < 0.05 versus thermoneutral conditions; † P < 0.05 versus young.
Additionally, the muscle metaboreflex response was preserved in older adults and unaffected by L-tyrosine supplementation and/or cooling. Although it is unlikely that an acute oral dose of L-tyrosine affected blood pressure regulation during exercise, it is apparent that it affected thermoregulatory mechanisms in skin. L-Tyrosine is the primary substrate for catecholamine biosynthesis. The initial and rate-limiting step for producing noradrenaline is the hydroxylation of L-tyrosine, which is catalysed by the enzyme TH (Nagatsu et al. 1964; Kumer & Vrana, 1996) . Tetrahydrobiopterin (BH 4 ) is an essential cofactor in this reaction because it reduces the iron moiety of TH to its active ferrous form, thereby priming the enzyme for subsequent hydroxylation of L-tyrosine (Kaufman, 1978; Frantom et al. 2006; Thöny et al. 2008) . In an 'activated state' , such as during cold or exercise stress, TH ultimately depends on increased bioavailability of both the amino acid substrate and the pterin cofactor (Kumer & Vrana, 1996; Dunkley et al. 2004 ). During cold exposure in rats, the intracellular concentration of BH 4 doubles with an elevation in sympathetic nerve activity (Baruchin et al. 1990 ). In humans, BH 4 supplementation with oral ingestion of a synthetic analogue, sapropterin, or with local intradermal administration augments the reflex VC response to whole-body cooling as well as the VC response elicited pharmacologically with tyramine (Lang et al. 2009; Stanhewicz et al. 2013) . After sympathetic activation and subsequent priming of TH with BH 4 , catecholamine synthesis ultimately depends on the bioavailability of
The notion that L-tyrosine concentration may limit catecholamine production does not seem likely because of its abundance from dietary protein sources (ß3-4 g day −1 ) as well as that produced endogenously in the liver (ß2-3 g day −1 ). Moreover, the K m for TH is below resting tyrosine concentrations (Morgenroth et al. 1976; Joh et al. 1978; Fernstrom, 1983) . However, in an activated state, tyrosine in the immediate vicinity of TH may affect catecholamine synthesis (Carlsson & Lindqvist, 1978; Sved & Fernstrom, 1981; Fernstrom et al. 1984; Milner & Wurtman, 1986; During et al. 1989 ). This phenomenon is particularly evident when TH activation is coupled with limited tyrosine bioavailability (Wurtman et al. 1974; Fernstrom & Fernstrom, 1995; McTavish et al. 1999; Bongiovanni et al. 2008 Bongiovanni et al. , 2012 . This may be the case in older adults despite the fact that resting blood tyrosine is unaffected with age (Caballero et al. 1991) . Increased oxidative and nitrosative stress in aged skin may be diminishing axonal tyrosine by converting L-tyrosine to byproducts, such as 3-nitrotyrosine or tyrosyl radical, that are incapable of participating in catecholamine biosynthesis (Kooy & Lewis, 1996; Reiter et al. 2000; Blanchard-Fillion et al. 2001; Kochman et al. 2002; Nishigori et al. 2003) . This is supported by evidence in peripheral tissues that noradrenaline release is reduced in response to variety of stressors in aged rats (Cizza et al. 1995; McCarty et al. 1997) . Thus, reduced bioavailability of tyrosine may be manifested in older adults as a blunted end-organ response to reflex adrenergic stimulation and impaired ability to maintain homeostasis during various stressors.
During whole-body cold stress, it is well established that the reflex cutaneous VC response is blunted in aged skin (Kenney & Armstrong, 1996; Thompson & Kenney, 2004; Lang et al. 2009 ). In young adults, ß60% of the reflex VC response in mediated by noradrenaline and the remainder is attributable to other co-released neurotransmitters (Stephens et al. 2001) . In contrast, older adults rely on a blunted noradrenergic response to elicit VC, and the cotransmitter component is functionally absent (Thompson et al. 2005; Lang et al. 2010) . Loss of redundancy and impaired vasoconstrictor function in older adults may increase their susceptibility to excess heat loss and hypothermia even in mildly cool ambient conditions (Kenney & Armstrong, 1996; Thompson & Kenney, 2004; DeGroot & Kenney, 2007) . However, local intradermal administration of L-tyrosine in aged skin augmented the cutaneous VC response elicited by whole-body cooling or pharmacologically by tyramine perfusion. This is supported by the present study, in which oral ingestion of L-tyrosine increased the reflex cutaneous and the forearm vasoconstrictor response to cold exposure in older adults.
During isometric hand-grip exercise stress, there is an increase in sympathetic nerve activity and blood pressure attributable in large part to the stimulation of metabosensitive afferents by chemical byproducts of muscle contraction (McCloskey & Mitchell, 1972; Mark et al. 1985; Victor et al. 1988 Victor & Seals, 1989) . This muscle metaboreflex component can be isolated experimentally by PEI following hand-grip exercise (Alam & Smirk, 1937) . At rest, older adults exhibit elevated muscle sympathetic nerve activity (Ng et al. 1993) , increased plasma noradrenaline (Esler et al. 1981 (Esler et al. , 1995 Hoeldtke & Cilmi, 1985) and reduced sensitivity of α-adrenergic receptors (Hogikyan & Supiano, 1994; Davy et al. 1998; Dinenno et al. 2001) . Presumably, this environment would diminish the substrate available for catecholamine biosynthesis when sympathetic activity is increased. However, with muscle metaboreflex activation the change in MAP during exercise or PEI was not different between age groups. These findings were consistent with other studies (Taylor et al. 1991; Ng et al. 1994; Roseguini et al. 2007; Greaney et al. 2014) . The addition of cooling, whether localized to the arm (Ray et al. 1997) or whole-body cooling (Greaney et al. 2014) , did not alter the change in blood pressure during static hand-grip exercise in older adults. Our findings support these studies and additionally demonstrate that oral L-tyrosine supplementation did not alter the pressor response to static hand-grip exercise in young or older adults in thermoneutral or whole-body cooling conditions.
Oral supplementation of L-tyrosine in humans has been investigated during cold exposure. In soldiers subjected to prolonged stressful environmental conditions, L-tyrosine supplementation offset cold-related decreases in working memory, marksmanship, adverse moods, adverse behavioural effects and performance impairments (Banderet & Lieberman, 1989; Mahoney et al. 2007; O'Brien et al. 2007) . In the present study, participants acutely ingested ß1.5-2 times the normal daily intake of L-tyrosine, which augmented the reflex cutaneous VC response to whole-body cooling. However, this was evident only in older adults, which suggests that L-tyrosine uniquely limits noradrenergic function in this population during cold stress. Putative mechanisms explaining this phenomenon include the following: (i) reduced axonal tyrosine bioavailability secondary to an age-related increase in oxidative and nitrosative stress; and (ii) blunted increases in skin sympathetic nerve activity during cold stress, thereby reducing the stimulus for tyrosine hydroxylase activation.
Limitations
One limitation of this study is that the observed peripheral vascular changes might be influenced by central mechanisms. However, the increase in VC during whole-body cooling with oral L-tyrosine ingestion was similar to that measured with localized administration of tyrosine (Lang et al. 2010) . A second limitation may be that the 40 min gradual cooling protocol used in the present study did not elicit a decrease in body core temperature and might not have been a sufficient stimulus to discriminate whether or not a supplement effect exists in young adults. Although tyrosine was observed to be a limiting factor in aged skin, tyrosine also did not affect blood pressure with metaboreflex activation. This assessment was limited by the fact that muscle sympathetic nerve activity was not measured in this protocol. A previous study that incorporated six 1 min bouts of rhythmic hand-grip exercise (30 1 s contractions per minute at 30% MVC) while forearm pressure was progressively increased to 50 mmHg found that, compared with young adults, the increase in blood pressure was blunted in older adults (Markel et al. 2003) . It is plausible that tyrosine does indeed affect the blood pressure response but that the intensity or duration of the stress in the present study was not sufficient to limit adrenergic function.
Conclusions
In summary, acute oral L-tyrosine supplementation largely restored the blunted cutaneous vasoconstriction response to whole-body cooling in older adults. However, the blood pressure response to muscle metaboreflex activation was preserved in older adults and remained unaffected by tyrosine ingestion. Collectively, this suggests that the axonal pool of tyrosine immediately available to tyrosine hydroxylase during sympathetic activation may limit adrenergic function in older adults. Whether this ultimately impacts thermoregulatory function and preservation of body core temperature during cold exposure has yet to be investigated.
